Validated high-performance liquid chromatographic method for the determination of lamotrigine in human plasma

被引：49

作者：

Barbosa, NR ^{[1
]}

Mídio, AF ^{[1
]}

机构：

[1] Univ Sao Paulo, Fac Ciencias Farmaceut, Dept Anal Clin & Toxicol, BR-05508900 Sao Paulo, Brazil

来源：

JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES | 2000年 / 741卷 / 02期

关键词：

lamotrigine;

D O I：

10.1016/S0378-4347(00)00102-X

中图分类号：

Q5 [生物化学];

学科分类号：

071010 ; 081704 ;

摘要：

A high-performance liquid chromatographic (HPLC) procedure for lamotrigine was developed and validated. Lamotrigine (LTG) and an internal standard were extracted from plasma using liquid-liquid extraction under alkaline conditions into an organic solvent. The method was linear in the range 0.78-46.95 mu mol/l, with a mean coefficient of correlation (r)greater than or equal to 0.99923. The limit of detection (LOD) and limit of quantification (LOQ) were 0.19 and 0.58 mu mol/l, respectively. Within- and between-run precision studies demonstrated C.V.<3% at all tested concentrations. LTG median recovery was 86.14%. Antiepileptic drugs tested did not interfere with the assay. The method showed to be appropriate for monitoring LTG in plasma samples. (C) 2000 Elsevier Science B.V. All rights reserved.

引用

页码：289 / 293

页数：5

共 24 条

[21]

SVENSSON JO, 1995, THER DRUG MONIT, V17, P408

[22] Analysis of the antiepileptic phenyltriazine compound lamotrigine using gas chromatography with nitrogen phosphorus detection [J].

Watelle, M ;

Demedts, P ;

Franck, F ;

DeDeyn, PP ;

Wauters, A ;

Neels, H .

THERAPEUTIC DRUG MONITORING, 1997, 19 (04) :460-464

[23] SODIUM VALPROATE ACUTELY INHIBITS LAMOTRIGINE METABOLISM [J].

YUEN, AWC ;

LAND, G ;

WEATHERLEY, BC ;

PECK, AW .

BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1992, 33 (05) :511-513

[24] LAMOTRIGINE - A REVIEW OF ANTIEPILEPTIC EFFICACY [J].

YUEN, AWC .

EPILEPSIA, 1994, 35 :S33-S36

← 1 2 3 →